These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of topical tacrolimus ointment on expression of Toll-like receptors 2 and 4 in lesional atopic dermatitis skin].
    Author: Xie ZQ, Liu LL, Yang GY, Zhu XJ.
    Journal: Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug 18; 38(4):420-3. PubMed ID: 16892151.
    Abstract:
    OBJECTIVE: To investigate the role of Toll-like receptor(TLR) 2 and TLR4 in pathogenesis of atopic dermatitis(AD) and the effect of topical tacrolimus ointment on expression of TLR2 and TLR4 in lesional AD skin. METHODS: Immunohistochemistry was employed to study the expression of TLR2 and TLR4 in normal skin and lesional AD skin before and after using topical tacrolimus ointment. RESULTS: The basal keratinocytes in normal skin constitutively expressed TLR2 and TLR4. In contrast, lesional epidermis from 9 patients with acute AD overexpressed TLR2 and TLR4 on the whole epidermis keratinocytes with membranous and cytoplasmic staining pattern. After using topical tacrolimus ointment for three weeks, TLR2 and TLR4 were expressed on basal and suprabasal keratinocytes with membranous and cytoplasmic staining pattern. CONCLUSION: These data suggest that TLR2 and TLR4 expressed by epidermal keratinocytes constitute part of the innate immune system of the skin, and increased TLR2 and TLR4 expression may be related to the skin innate immuno-inflammatory response in atopic dermatitis. Topical tacrolimus may directly or indirectly inhibit or down-regulate TLR2 and TLR4 expression in KC and inhibit skin innate immuno-inflammatory response related to TLR-NFkappaB signal transduction and regulation in atopic dermatitis.
    [Abstract] [Full Text] [Related] [New Search]